Urologix (ULGX) Closes 5.2M Offering, Full-Allotment Exercised
Tweet Send to a FriendGet Alerts ULGX Hot Sheet
Up)
Trade ULGX Now!
Urologix, Inc. (Nasdaq: ULGX), announced the sale of an additional 780,000 shares of its common stock at a price to the public of $0.75 per share. The sale was pursuant to a 45-day over-allotment option granted to the underwriter as part of the Company's recently completed public offering of 5,200,000 shares of its common stock that closed July 5, 2012. Urologix received proceeds of approximately $544,000, after underwriter discounts, from the sale of the over-allotment shares.
Dougherty & Company LLC served as the sole underwriter for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Dougherty & Company LLC served as the sole underwriter for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Kodak (EKDKQ) Asks Court to Approve $406M Rights Offering on Bankruptcy Emergence
- Gladstone Commercial (GOOD) Prices Upsized 1.32M Common Stock Offering
- Microsoft (MSFT) Announces Change to Xbox One Resell Rules (GME)
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Dougherty & Company
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
